AKT1 and colorectal carcinoma: Moreover, the immunoblotting results confirmed that IR treatment further reduced Akt activity and downstream kinase GSK3β, in Skp2 knockout HCT116 and HT29 cells (Supplementary Fig. 2B, C), indicating that Skp2 is required for Akt signaling activation in CRC cells even with IR treatment.